個股熱度排行 | 1月9日港股盤前
根據uSMART輿情監測數據，週末期間，市場關注指數最高的5只股票是阿裏巴巴-SW、比亞迪股份、小鵬汽車-W、龍湖集團、復星醫藥。
1月9日—港股關注排行TOP5
阿裏巴巴-SW
關注度第一爲阿裏巴巴-SW，該股上個交易日收盤上漲2.01%，報於101.60港元。近5個交易日累計上漲18.76%。在消息面和社交媒體方面，輿情以看空爲主。較被市場關注的消息有：
阿裏巴巴緊急捐贈1.25億元 爲全國60多萬個村每村配備兩臺血氧儀
阿裏巴巴-SW：馬雲將不再控制君瀚和君澳持有的螞蟻集團多數投票權
比亞迪股份
關注度第二爲比亞迪股份，該股上個交易日收盤下跌2.60%，報於202.40港元。近5個交易日累計上漲5.97%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
2022年更名和換LOGO的40個大公司和品牌：阿裏巴巴、比亞迪、百威英博、賽諾菲都換標了
比亞迪董事長兼總裁王傳福當選2022中國經濟年度人物
小鵬汽車-W
關注度第三爲小鵬汽車-W，該股上個交易日收盤下跌6.82%，報於41.00港元。近5個交易日累計上漲9.19%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
美股開市前：特斯拉跌逾6% 小鵬汽車跌11% WWE飆升10%
美股收盤：道指漲近700點 中概新能源車股重挫小鵬汽車跌15%
龍湖集團
關注度第四爲龍湖集團，該股上個交易日收盤上漲1.85%，報於27.50港元。近5個交易日累計上漲16.53%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
國美零售再獲控股股東黃光裕提供無息貸款；龍湖集團2022年度累計實現總合同銷售額2015.9億元
龍湖集團：22年總合同銷售金額人民幣2015.9億元
復星醫藥
關注度第五爲復星醫藥，該股上個交易日收盤下跌0.75%，報於26.45港元。近5個交易日累計上漲3.93%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
復星醫藥：寧波復瀛擬0元受讓蘇州基金、天津基金份額 均專注於大健康領域
復星醫藥控股子公司擬增持蘇州基金與天津基金份額
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
